Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleTotal Intravenous Anesthesia and Recurrence Free Survival
- Where
- Shanghai
- Age
- 18 years to 90 years
- People
- 1,614
- Run by
- The Cleveland Clinic
See details and how to joinNCT04513808 - No phaseTaking peopleExploring the Difference Between Gastric Cardia Cancer and Non-cardia Gastric Cancer Based on Multiomics
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 120
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT05812287 - Phase 1Not yet taking people in ChinaPhase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 18
- Run by
- Beijing Anjianxi Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07806500 - Phase 1/2Taking peopleSubstudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
- Where
- Beijing, Fuzhou, Hangzhou, Nanchang, Shanghai, Ürümqi, Xiamen, Zhengzhou
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06445972 · EU 2023-509306-29-00 - Phase 2Not yet taking people in ChinaPhase II Study of Trastuzumab Rezetecan Combined With Retlirafusp Alfa With or Without CAPOX as Perioperative Therapy for Resectable Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 80
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07802288 - No phaseTaking peopleSafety and Short-term Outcomes of Modular Robotic System for Siewert II/III Gastroesophageal Junction Cancer
- Where
- Changchun
- Age
- 18 years to 80 years
- People
- 25
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT07790809 - Phase 2Not yet taking people in ChinaPaclitaxel Polymeric Micelles and Cisplatin Plus Sintilimab as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Hebei
- Age
- 18 years to 75 years
- People
- 32
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07799077 - No phaseNot yet taking people in ChinactDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 150
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07799649 - No phaseNot yet taking people in ChinaSino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract Reconstruction
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 250 worldwide
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07800819 - Phase 2Taking peoplePDL1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer
- Where
- Zhengzhou
- Age
- 18 years and over
- People
- 78
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT07294664 - No phaseTaking peopleThe Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer
- Where
- Changchun
- Age
- 18 years to 75 years
- People
- 300
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT06881043 - No phaseTaking peopleCT Imaging and Clinical Features to Predict Outcomes in Patients With Gastric Cancer
- Where
- Wuhan
- Age
- 18 years and over
- People
- 600
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07776067 - No phaseTaking peopleValidating a Medical AI Fine-Tuning Platform for Major Diseases
- Where
- Beijing
- Age
- 18 years and over
- People
- 96,000
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07795645 - Phase 2Taking peopleAdebrelimab With Famitinib and Chemotherapy as Neoadjuvant Therapy for ESCC
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 24
- Run by
- First Affiliated Hospital Xi'an Jiaotong University
See details and how to joinNCT07796113 - No phaseTaking peopleThe Effect of Different Digestive Tract Reconstruction Methods on Postoperative Quality of Life After Proximal Gastrectomy
- Where
- Changchun
- Age
- 18 years to 75 years
- People
- 90
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT06929949 - No phaseNot yet taking people in ChinaHigh-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 90
- Run by
- Zhejiang University
See details and how to joinNCT07791979 - Phase 2Not yet taking people in ChinaTR115 in ARID1A-Mutated Advanced Solid Tumors
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 50
- Run by
- Tarapeutics Science Inc.
See details and how to joinNCT07793318 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Anyang, Baoding, Beijing, Bengbu, Changchun, Changsha, Changzhou, Chongqing, Guangzhou, Hangzhou, Hefei, Hongcun, Jinan, Jining, Kunming, Lanzhou, Liaocheng, Nanchang, Nanning, Shanghai, Shenyang, Tianjin, Wenzhou, Wuhan, Wuxi, Xiamen, Xi’an, Xuzhou, Yantai, Yulin, Zhengzhou, Zibo
- Age
- 18 years and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691 - Phase 1Taking peopleA Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
- Where
- Beijing, Chengdu, Hangzhou, Jinan, Nanchang, Tianjin
- Age
- 18 years to 75 years
- People
- 96
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05262491 - No phaseTaking peopleInvestigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma
- Where
- Chengdu, Shantou, Taiyuan, Wuwei, Xi'an, Yan’an, Zhaoqing, Zhengzhou
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Xijing Hospital
See details and how to joinNCT06979869 - No phaseTaking peopleInvestigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 150
- Run by
- Xijing Hospital
See details and how to joinNCT06979895 - No phaseEnrolling by invitationLarge-scale Models of Esophageal Cancer and Related Research
- Where
- Anyang, Luoyang, Nanyang
- Age
- 18 years to 90 years
- People
- 12,000
- Run by
- The First Affiliated Hospital of Henan University of Science and Technology
See details and how to joinNCT07642401 - Phase 3Not yet taking people in ChinaA Non-inferiority Study of Indocyanine Green-guided Sentinel Lymph Node Mapping Versus Conventional Lymph Node Dissection in Esophageal Cancer
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 200
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT07788001 - Phase 2Taking peopleA Clinical Study Comparing Anti-HER2 Therapy Combined With Chemotherapy to Chemotherapy Alone as Adjuvant Therapy Following Surgery for Stage IB-II Gastric Cancer With High HER2 Expression.
- Where
- Xi'an
- Age
- 18 years and over
- People
- 120
- Run by
- Xijing Hospital
See details and how to joinNCT07788196 - Phase 2Not yet taking people in ChinaA Sequential Trial of Low-Dose Radiotherapy Followed by Concurrent Immunotherapy, Systemic Chemotherapy, and Intraperitoneal Perfusion in Gastric Cancer With Peritoneal Carcinomatosis
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 40
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT07784413